AMD Performance Labs

Latest stories

27d
Business Wire
SciFluor Life Sciences Enters Clinical Trial Stage for Novel Treatment for Retinal Diseases(SF0166). This enables the company to initiate clinical testing of SF0166 in bo
SciFluor Life Sciences Enters Clinical Trial Stage for Novel Treatment for Retinal Diseases
Business Wire / Posted 27 days ago
(SF0166). This enables the company to initiate clinical testing of SF0166 in both wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) patients, two retinal diseases that are among the leading causes of blindness... Read more

People in this news